Skip to content
Tenfell
Closed tender
Published 26 Jan 2026

Next Generation Sequencing Testing (NGS)

NHS Blood and Transplant · United Kingdom

Key facts

Estimated value
£600,000
Closing date
20 Feb 2026
Contract ends
31 Mar 2027
Procedure
Competitive flexible procedure
Buyer type
Health

Description

NHS Blood and Transplant (NHSBT) are seeking a provider for Next Generation Sequencing (NGS) QC testing requirements for the Cellular and Molecular Therapies (CMT) directorate, namely the Clinical Biotechnology Centre (CBC). CBC handle a number of products in the production of Advanced Therapeutic Investigational Medicinal Products (ATMPs) and starter material master cell banks (MCBs). These require NGS QC testing services that meet specific regulatory requirements.

Categories (CPV)

Similar open tenders

About NHS Blood and Transplant

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.